Current Management of the Short Bowel Syndrome

Surgical Clinics of North America

Volumn 91, Issue 3, 2011, Pages 493-510

  Thompson, Jon S ^a   Weseman, Rebecca ^b   Rochling, Fedja A ^a   Mercer, David F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Intestinal failure; Intestinal transplantation; Short bowel syndrome

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM; CARBOHYDRATE; CLONIDINE; COLESTYRAMINE; DIPHENOXYLATE; EPIDERMAL GROWTH FACTOR; FAT; GLUTAMINE; GROWTH HORMONE; HISTAMINE H2 RECEPTOR ANTAGONIST; LOPERAMIDE; MAGNESIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NARCOTIC AGENT; OCTREOTIDE; OXALIC ACID; PANCREAS ENZYME; PROBIOTIC AGENT; PROKINETIC AGENT; PROTEIN; PROTON PUMP INHIBITOR; SOMATOSTATIN; STEROID; TACROLIMUS; TEDUGLUTIDE; VITAMIN D;

ABSORPTION; BACTERIAL GROWTH; CHOLELITHIASIS; DIARRHEA; DIET THERAPY; DRUG MEGADOSE; FIBER; GASTROINTESTINAL SECRETION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTIOUS COMPLICATION; INTESTINE TRANSPLANTATION; LIVER DISEASE; MORTALITY; NEPHROLITHIASIS; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; SHORT BOWEL SYNDROME; STEATORRHEA; SURVIVAL; VITAMIN SUPPLEMENTATION;

COMBINED MODALITY THERAPY; ENTERAL NUTRITION; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MALNUTRITION; NUTRITIONAL STATUS; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME;

EID: 79957576623     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2011.02.006     Document Type: Review

References (67)

1. O'Keefe S.J., Buchman A.L., Fishbein T.M., et al. Short bowel syndrome and intestinal failure: consensus, definitions, and overview. Clin Gastroenterol Hepatol 2006, 4:6-10.
2. Buchman A.L., Scolapio J., Fryer J. American Gastroenterological Association Medical Position Statement: short bowel syndrome and intestinal transplantation. Gastroenterology 2003, 124:1105-1110.
3. Howard L., Ament M., Fleming C.R., et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995, 109:355-365.
4. Thompson J.S., Langnas A.N., Pinch L.W., et al. Surgical approach to the short bowel syndrome. Ann Surg 1995, 222:600-607.
5. Thompson J.S. Comparison of massive versus repeated resections leading to the short bowel syndrome. J Gastrointest Surg 2000, 4:101-104.
6. Messing B., Crenn P., Beau P., et al. Long-term survival and parenteral nutrition dependence in adult patients with short bowel syndrome. Gastroenterology 1999, 117:1043-1050.
7. Cavicchi M., Beau P., Crenn P., et al. Prevalence of liver disease as a contributing factor in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000, 132:525-532.
8. Drozdowski L., Thomson A.B. Intestinal mucosal adaptation. World J Gastroenterol 2006, 12:4614-4627.
9. Dibaise J., Young R.J., Vanderhoof J.A., et al. Intestinal rehabilitation and the short bowel syndrome. Am J Gastroenterol 2004, 99:1823-1832.
10. Rhoda K.M., Parekh N.R., Lennon E., et al. The multidisciplinary approach to the care of patients with intestinal failure at a tertiary care facility. Nutr Clin Pract 2010, 25:183-191.
11. Carbonnel F., Cosnes J., Chevret B.L., et al. The role of anatomic factors in nutritional autonomy after extensive bowel resection. JPEN J Parenter Enteral Nutr 1996, 20:275-280.
12. Nordgaard I., Hensen B.S., Mortensen P.B. Colon as a digestive organ in patients with short bowel. Lancet 1994, 343:373-376.
13. Jeppesen P.B., Mortensen P.B. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998, 43:478-483.
14. Dibaise J., Matarese L.E., Messing B., et al. Strategies for parenteral nutrition weaning in adult patients with short bowel syndrome. J Clin Gastroenterol 2006, 40:594-598.
15. Crenn P., Morin M.C., Joly F., et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut 2004, 3:1279-1286.
16. Levy E., Frileux P., Sandrucci S., et al. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg 1988, 75:549-553.
17. Shatnawei A., Parekh N.R., Rhoda K.M., et al. Intestinal failure management at the Cleveland Clinic. Arch Surg 2010, 145:521-527.
18. Atia A.N., Buchman A.L. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol 2009, 104:2596-2604.
19. Jeppesen P.B., Hoy C.E., Mortensen P.B. Deficiencies of essential fatty acids, vitamin and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr 2000, 54:632-642.
20. Van der Hulst R.R., Van Kreel B.K., Von Meyenfeldt M.F., et al. Glutamine and the preservation of gut integrity. Lancet 1993, 341:1363-1365.
21. Byrne T.A., Persinger R.L., Young L.S., et al. A new treatment for patients with short-bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg 1995, 222:243-255.
22. Byrne T.A., Morrissey T.B., Nattakom T.V., et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995, 19:296-302.
23. Byrne T.A., Wilmore D.W., Iyer K., et al. Growth hormone, glutamine and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome. Ann Surg 2005, 242:655-661.
24. Jeppesen P.B., Hartmann B., Thulesen J., et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001, 120:806-815.
25. Jeppesen P.B., Sanquinetti E.L., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase-IV resistant glucagon like peptide-2 (GLP-2) analog, improves intestinal function in short bowel syndrome patients. Gut 2005, 54:1224-1231.
26. Jeppeson P.B., Stann M., Tjellessen L. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium and macronutrients in patients with intestinal resection. Gut 1998, 43:763-769.
27. Compare D., Pica L., Rocco A., et al. Effects of long-term PPI treatment on producing bowel symptoms and bacterial overgrowth. Eur J Clin Invest 2010, 10:1365.
28. O'Keefe S.J., Haymond M.W., Bennet W.M., et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994, 107:379-388.
29. Catnach S.M., Anderson J.V., Fairclough P.D., et al. Effect of octreotide on gallstone prevalence and gallbladder motility in acromegaly. Gut 1993, 34:270-273.
30. McDaniel K., Taylor B., Huey W., et al. Use of clonidine to decrease intestinal fluid losses in patients with high-output short bowel syndrome. JPEN J Parenter Enteral Nutr 2004, 28:265-268.
31. Joly F.L., Mayeuv C., Bruneau A., et al. Drastic changes in fecal and mucosa associated microbiota in adult patients with short bowel syndrome. Biochimie 2010, 92:753-761.
32. Stoidis C.N., Misiakos E.P., Patapis P., et al. Potential benefits of pro and prebiotics on intestinal mucosal immunity and intestinal barrier in short bowel syndrome. Nutr Res Rev 2010, 21:1-9.
33. Jeppesen P.B. The use of hormonal growth factors in the treatment of patients with short bowel syndrome. Drugs 2006, 66:581-589.
34. Seguy D., Kvahedi K., Kapel N., et al. Low-dose growth hormone in adult home parenteral nutrition dependent short bowel syndrome patients: a positive study. Gastroenterology 2003, 124:293-302.
35. Scolapio J.S., Camilleri M., Fleming C.R., et al. Effect of growth hormone, glutamine, and diet on adaption in short bowel syndrome: a randomized controlled trial. Gastroenterology 1997, 115:1074-1081.
36. Szkudlarek J., Jeppesen P.B., Mortensen P.B. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patient: a randomized, double blind, crossover, placebo controlled study. Gut 2000, 47:199-205.
37. Wales P.W., Nasr A., deSilva N., et al. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev 2010, 6. CD006321.
38. Jeppesen P.B., Lund P., Gottschalck I.B., et al. Short bowel patients treated for 2 years with GLP 2: compliance, safety and effects on quality of life. Gastroenterol Res Pract 2009, 2009:425759.
39. Thompson J.S. EGF and the short bowel syndrome. JPEN J Parenter Enteral Nutr 1999, 23:S113-S116.
40. Sigalet D.L., Martin G.R., Butzner J.D., et al. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg 2005, 40:763-768.
41. Howard L., Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology 2003, 124:1651-1661.
42. O'Keefe S.J., Burnes J.U., Thompson R.L. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. JPEN J Parenter Enteral Nutr 1994, 18:256-263.
43. Opilla M.T., Kirby D.F., Edmund M.B. Use of ethanol lock therapy to reduce the incidence of catheter related blood stream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 2007, 31:302-305.
44. Kelly D.A. Preventing parenteral nutrition liver disease. Early Hum Dev 2010, 86:683-687.
45. DiBaise J.K., Young R.J., Vanderhoof J.A. Enteric microbial flora, bacterial overgrowth and short bowel syndrome. Clin Gastroenterol Hepatol 2006, 4:11-20.
46. Quigley E.M., Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am 2010, 24:943-959.
47. Nightingale J.M., Lennard-Jones J.E., Gertner D.J., et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gallstones in patients with a short bowel. Gut 1992, 33:1493-1497.
48. Dray X., Joly F., Reijasse D., et al. Incidence, risk factors and complications of cholelithiasis in patients with home parenteral nutrition. J Am Coll Surg 2007, 204:13-21.
49. Thompson J.S. The role of prophylactic cholecystectomy in the short bowel syndrome. Arch Surg 1996, 131:556-660.
50. Thompson J.S. Reoperation in patients with the short bowel syndrome. Am J Surg 1992, 164:453-457.
51. Thompson J.S. Surgical rehabilitation of intestine in short bowel syndrome. Surgery 2004, 35:465-470.
52. Nguyen B.T., Blatchford G.J., Thompson J.S., et al. Should intestinal continuity be restored after massive intestinal resection?. Am J Surg 1989, 158:577-580.
53. Siepler J.K., Nishikawa R.A., Diamantidi S.T., et al. Exit site infections are more common in patients with ostomies. JPEN J Parenter Enteral Nutr 2007, 31:55.
54. Thompson J.S., Langnas A.N. Surgical approaches to improving intestinal function in Short Bowel Syndrome. Arch Surg 1999, 134:706-771.
55. Thompson J.S., Sudan D.A. Intestinal lengthening in the short bowel syndrome. Advances in Surgery 2008, volume 42:49-61. Mosby, St Louis (MO). J. Cameron (Ed.).
56. Thompson J.S. Surgical approach to the short bowel syndrome: procedures to slow intestinal transit. Eur J Pediatr Surg 1999, 9:263-266.
57. Thompson J.S., Sudan D.A., Gilroy R. Predicting outcome of procedures to slow intestinal transit. Transplant Proc 2006, 38:1838-1839.
58. Panis Y., Messing B., Rivet P., et al. Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg 1997, 225:401-407.
59. Sudan D., Thompson J.S., Botha J., et al. Comparisons of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007, 246:593-604.
60. Kim H., Fauza D., Garza J., et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003, 38:425-429.
61. Yannam G., Sudan D., Grant W., et al. Intestinal lengthening in adults with short bowel syndrome. J Gastrointest Surg 2010, 14:1931-1936.
62. Mazariegos G.V., Steffick D.E., Horslen S., et al. Intestinal transplantation in the United States 1999-2008. Am J Transplant 2010, 10:1020-1034.
63. Botha J.F., Grant W.J., Torres C., et al. Isolated liver transplantation in infants with end stage liver disease due to short bowel syndrome. Liver Transpl 2006, 12:1062-1066.
64. Grant D., Abu-Elmagd K., Reyes J., et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005, 241:607-613.
65. Abu-Elmagd K., Costa G., Bond G.J., et al. Five hundred intestinal and multivisceral transplantations at a single center. Ann Surg 2009, 250:567-581.
66. O'Keefe S.I.D., Emerling M., Kovitsky D., et al. Nutrition and quality of life following small intestinal transplantation. Am J Gastroenterol 2007, 102:1093-1100.
67. Sudan D. Long term outcomes and quality of life after intestinal transplantation. Curr Opin Organ Transplant 2010, 15:357-360.